Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei
PLoS Neglected Tropical Diseases, 05/08/2012Vincent IM et al.
Here, author present a new way of determining the mode of action of a drug by measuring how the levels of small molecules comprising the cellular metabolome are perturbed when exposed to drugs. They show that eflornithine causes the changes in polyamine metabolism previously known to underlie its mode of action.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.